订阅小程序
旧版功能

Neoadjuvant Treatment with Camrelizumab in Combination with Doxorubicin and Ifosfamide: A Phase II Clinical Study of High-Risk Soft Tissue Sarcoma.

Journal of Clinical Oncology(2024)

引用 0|浏览15
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要